Combinatory Treatment with Oseltamivir and Itraconazole Targeting Both Virus and Host Factors in Influenza A Virus Infection
Influenza virus infections and their associated morbidity and mortality are a major threat to global health. Vaccination is an effective influenza prevention measure; however, the effectiveness is challenged by the rapid changes in the influenza virus genome leading to viral adaptation. Emerging vir...
Main Authors: | Sebastian Schloer, Jonas Goretzko, Stephan Pleschka, Stephan Ludwig, Ursula Rescher |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/12/7/703 |
Similar Items
-
The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo
by: Sebastian Schloer, et al.
Published: (2019-01-01) -
Inhibition of Influenza Virus Replication by Oseltamivir Derivatives
by: Renee W. Y. Chan, et al.
Published: (2022-02-01) -
Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection in vitro
by: Susann Kummer, et al.
Published: (2022-12-01) -
Occurrence and characterization of oseltamivir-resistant influenza virus in children between 2007-2008 and 2008-2009 seasons
by: Seoung Geun Kim, et al.
Published: (2013-04-01) -
Effect of an Echinacea-Based Hot Drink Versus Oseltamivir in Influenza Treatment: A Randomized, Double-Blind, Double-Dummy, Multicenter, Noninferiority Clinical Trial
by: Karel Rauš, et al.
Published: (2015-12-01)